PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
21-Apr-2021 Alfa Chemistry Announces to Supply MOF Materials for the Science Communty Alfa Chemistry
21-Apr-2021 Amerigo Scientific Introduces SARS-CoV-2 IgM/IgG Antibody Test Kit to Researchers Amerigo Scientific
21-Apr-2021 STEMart Announces Medical Device Design Services for the Biomedical Industry STEMart
21-Apr-2021 CD Bioparticles Introduces Lipid Nanoparticle Formulation and Development for mRNA Vaccine Delivery CD Bioparticles
21-Apr-2021 Creative Diagnostics Introduces New SARS-CoV-2 Neutralizing Antibody ELISA Kit Creative Diagnostics
20-Apr-2021 Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss Rinri Therapeutics
20-Apr-2021 Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss Rinri Therapeutics
20-Apr-2021 MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit MeiraGTx
20-Apr-2021 Minagro’s co-formulant in-can preservative, Sovinol P740/O, gains Ecocert certification Andrew Lloyd Associates
19-Apr-2021 Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology Andrew Lloyd Associates
16-Apr-2021 Nouscom Activates Commercial Product License for ProBioGen’s Proprietary Vaccine Production Cell Line AGE1.CR.pIX® ProBioGen
16-Apr-2021 PharmiWeb.Jobs Welcomes Astellas Astellas
16-Apr-2021 PharmiWeb.Jobs Welcomes Medical Developments International Medical Developments International
15-Apr-2021 Top 10 Reasons to join SMi's 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference SMi Group
15-Apr-2021 Combat COVID-19, Pures Biotech Introduces New VirusOUT Bactericidal Tablet To Protect Against Viruses And Toxic Chemicals Pures Biotech Co., Ltd.
15-Apr-2021 IMCD AND HBC EXTEND INTERNATIONAL AGREEMENT TO INCLUDE EUROPE HBC
15-Apr-2021 TILT Biotherapeutics and MSD to collaborate on clinical trial of adenoviral cancer immunotherapeutic TILT-123 in combination with KEYTRUDA® (pembrolizumab) for ovarian cancer TILT Biotherapeutics
14-Apr-2021 Accelerating biopharmaceutical novelties: Körber joins the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Körber Business Area Pharma
13-Apr-2021 Co-innovation of Bioink and Powerful 2-Photon Bio-Printer Allows 3D-Printing with Living Cells for Bioapplications with Unprecedented Precision UpNano GmbH
13-Apr-2021 Oncurious NV Reports Encouraging Data from Phase 1 Dose Escalation Study of TB-403 in Paediatric Subjects with Relapsed or Refractory Medulloblastoma Presented at the American Association for Cancer Research 2021 Annual Meeting Oncurious NV